Plasma Sphingomyelins as Biomarkers for Diabetic Retinal Neurodegeneration: The Maastricht Study

Plasma Sphingomyelins as Biomarkers for Diabetic Retinal Neurodegeneration: The Maastricht Study

Objective: Sphingomyelin (SM) may play a role in the early stages of diabetic retinopathy. Early diagnosis of diabetic retinopathy is crucial for preventing the irreversible vision loss associated with this condition. This study aimed to examine the link between SM and key indicators of diabetic ret...

Full description

Saved in:
Bibliographic Details
Main Authors: Siddhita A. Jadhav, MSc, Birke J. Benedikter, PhD, Sara B.A. Mokhtar, MSc, Frank C.T. van der Heide, MD, PhD, Govindasamy Kumaramanickavel, MD, Marleen M.J. van Greevenbroek, PhD, Carroll A.B. Webers, MD, PhD, Tos T.J.M. Berendschot, PhD
Format: Article
Language:English
Published: Elsevier 2025-11-01
Series:Ophthalmology Science
Subjects:
Diabetic retinal neurodegeneration
Diabetic retinopathy
Sphingomyelin
Online Access:http://www.sciencedirect.com/science/article/pii/S266691452500168X
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items